FELDMAN MICHEL J 4
4 · WATSON PHARMACEUTICALS INC · Filed May 8, 2012
Insider Transaction Report
Form 4
FELDMAN MICHEL J
Director
Transactions
- Sale
Common Stock, par value $0.0033
2012-05-07$73.77/sh−20,000$1,475,400→ 13,177 total - Exercise/Conversion
Common Stock, par value $0.0033
2012-05-07$36.57/sh+20,000$731,400→ 33,177 total - Exercise/Conversion
Non-Qualified Options to Purchase Common Stock
2012-05-07−20,000→ 10,000 totalExercise: $36.57From: 2006-05-17Exp: 2014-05-17→ Common Stock, par value $0.0033 (20,000 underlying)
Holdings
- 1,000(indirect: By Spouse)
Common Stock, par value $0.0033
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.75 to $73.89, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.